Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT01416155

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Chiba, Japan
  • Research Site Fukuoka, Japan
  • Research Site Hiroshima, Japan
  • Research Site Sapporo, Hokkaido, Japan
View all 22 locations
View Trial Details
Completed

Safety and Tolerability of Glatiramer Acetate

NCT01874145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Teva Investigational Site 10706 Cullman, Alabama, United States
  • Teva Investigational Site 10719 Gilbert, Arizona, United States
  • Teva Investigational Site 10720 Phoenix, Arizona, United States
  • Teva Investigational Site 10727 Fresno, California, United States
View all 35 locations
View Trial Details
Completed

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

NCT00047580

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +23 more
Locations
  • Radiant Research Tucson, Arizona, United States
  • The Neurology Center Encinitas, California, United States
  • Northridge Neurological Center Northridge, California, United States
  • The Neurology Center Oceanside, California, United States
View all 16 locations
View Trial Details

Related conditions